Iman Osman

Iman Osman

UNVERIFIED PROFILE

Are you Iman Osman?   Register this Author

Register author
Iman Osman

Iman Osman

Publications by authors named "Iman Osman"

Are you Iman Osman?   Register this Author

100Publications

2756Reads

30Profile Views

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.

Genome Med 2019 Oct 9;11(1):61. Epub 2019 Oct 9.

Department of Population Health, NYU School of Medicine, New York, NY, 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13073-019-0672-4DOI Listing
October 2019

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.

Cancer Immunol Immunother 2019 Jun 12;68(6):897-905. Epub 2019 Mar 12.

Laura and Issac Perlmutter Cancer Center, New York University School of Medicine, 522 First Avenue, New York, NY, 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02318-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531317PMC
June 2019

Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples.

J Mol Diagn 2019 Mar 26;21(2):274-285. Epub 2018 Oct 26.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419583PMC
March 2019

Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma.

J Invest Dermatol 2019 Feb 24;139(2):430-438. Epub 2018 Aug 24.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X183250
Publisher Site
http://dx.doi.org/10.1016/j.jid.2018.07.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342667PMC
February 2019

Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.

J Surg Oncol 2018 Jul 7;118(1):150-156. Epub 2018 Jun 7.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25111DOI Listing
July 2018

Quality Assurance After a Natural Disaster: Lessons from Hurricane Sandy.

Biopreserv Biobank 2018 Apr 3;16(2):92-96. Epub 2018 Jan 3.

4 Department of Pathology, Center for Biospecimen Research and Development, New York University Langone Health , New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2017.0104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906721PMC
April 2018

Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.

Oncology 2017 27;93(4):249-258. Epub 2017 Jul 27.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000478050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617794PMC
January 2018

Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care.

Oncology 2017 10;93(3):164-176. Epub 2017 Jun 10.

The Ronald O. Perelman Department of Dermatology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000475715DOI Listing
December 2017

Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.

Mod Pathol 2017 10 21;30(10):1402-1410. Epub 2017 Jul 21.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.64DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640153PMC
October 2017

A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.

Cancer Cell 2017 06;31(6):804-819.e7

Department of Pathology, New York University School of Medicine, New York, NY 10016, USA; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649440PMC
June 2017

Corrigendum to "Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma" (Hum Pathol 2016;57:116-25).

Hum Pathol 2017 05 25;63:222. Epub 2017 Apr 25.

Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, NY, USA 10016; Department of Pathology, New York University School of Medicine, New York, NY, USA 10016. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.03.001DOI Listing
May 2017

Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.

J Neurooncol 2017 01 7;131(2):341-348. Epub 2016 Nov 7.

Department of Radiology, NYU School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2305-8DOI Listing
January 2017

Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.

Hum Pathol 2016 11 26;57:116-125. Epub 2016 Jul 26.

Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, NY, USA 10016; Department of Pathology, New York University School of Medicine, New York, NY, USA 10016. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.07.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706446PMC
November 2016

De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.

J Natl Cancer Inst 2016 10 27;108(10). Epub 2016 May 27.

Affiliations of authors: The Ronald O. Perelman Department of Dermatology (RMC, ECM, LAP, IO, DP) and Department of Population Health (YS, KW, YZ), New York University School of Medicine; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY (YS, IO, DP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939856PMC
October 2016

Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.

J Transl Med 2016 10 19;14(1):299. Epub 2016 Oct 19.

Interdisciplinary Melanoma Cooperative Group, NYU School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-1026-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070187PMC
October 2016

The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.

Clin Cancer Res 2016 07 5;22(13):3268-80. Epub 2016 Jan 5.

Perlmutter Cancer Center, New York University School of Medicine, New York, New York. Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, New York. The Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/01/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024570PMC
July 2016

Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.

J Immunol 2016 07 6;197(2):644-54. Epub 2016 Jun 6.

Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016; Department of Pathology, New York University School of Medicine, New York, NY 10016

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1600178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935560PMC
July 2016

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion.

Melanoma Res 2016 06;26(3):236-44

Departments of aPathology bDermatopathology cDermatology dPopulation Health eMedicine fMicrobiology gNYU Cancer Center, New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000235DOI Listing
June 2016

BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.

Cancer Med 2016 06 11;5(6):1183-93. Epub 2016 May 11.

Department of Pathology, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867668PMC
June 2016

Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.

Clin Cancer Res 2016 05 2;22(10):2377-85. Epub 2015 Dec 2.

The Ronald O. Perelman Department of Dermatology, New York, New York. The Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/02/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-1811DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867268PMC
May 2016

Synchronized Targeting of Notch and ERBB Signaling Suppresses Melanoma Tumor Growth through Inhibition of Notch1 and ERBB3.

J Invest Dermatol 2016 Feb 18;136(2):464-472. Epub 2015 Nov 18.

Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2015.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789778PMC
February 2016

Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.

Mol Oncol 2016 Jan 25;10(1):157-65. Epub 2015 Sep 25.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695284PMC
January 2016

Revisiting determinants of prognosis in cutaneous melanoma.

Cancer 2015 Dec 26;121(23):4108-23. Epub 2015 Aug 26.

Department of Medical Oncology, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666819PMC
December 2015

A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.

Clin Cancer Res 2015 Nov 18;21(21):4903-12. Epub 2015 Jun 18.

Department of Pathology, NYU School of Medicine, New York, NYU School of Medicine. Interdisciplinary Melanoma Cooperative Group, NYU Perlmutter Cancer Institute, NYU School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631639PMC
November 2015

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.

BMC Cancer 2015 Nov 23;15:926. Epub 2015 Nov 23.

Deparment of Medicine, New York University School of Medicine, 522 First Ave., Smilow Building Room 403, New York, NY, 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1927-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657192PMC
November 2015

MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.

Oncotarget 2015 Oct;6(32):33512-22

From the Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/5258
Publisher Site
http://dx.doi.org/10.18632/oncotarget.5258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741782PMC
October 2015

How microRNAs modify protein production.

J Invest Dermatol 2015 May;135(5):1-5

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2015.99DOI Listing
May 2015

Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.

J Med Genet 2015 Apr 20;52(4):231-9. Epub 2015 Jan 20.

Perlmutter Cancer Center, New York University School of Medicine, New York, USA Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, USA The Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2014-102832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166523PMC
April 2015

RSK1 activation promotes invasion in nodular melanoma.

Am J Pathol 2015 Mar 8;185(3):704-16. Epub 2015 Jan 8.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York; Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2014.11.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348467PMC
March 2015

Identification of metastasis-suppressive microRNAs in primary melanoma.

J Natl Cancer Inst 2015 Mar 12;107(3). Epub 2015 Feb 12.

Department of Pathology (DH, MFS, EP, XJS, FD, EH), Interdisciplinary Melanoma Cooperative Group (DH, MFS, JZ, XJS, FD, RSB, RLS, AP, IO, EH), Department of Environmental Medicine (JZ), Department of Dermatology (AP, IO), Department of Medicine (AP, IO), Department of Urology (IO); Department of Surgery (RSB, RLS), NYU Langone Medical Center, New York, NY; Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY (BB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju494DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565532PMC
March 2015

Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma.

Sci Signal 2015 Mar 10;8(367):ra27. Epub 2015 Mar 10.

Department of Medicine, New York University School of Medicine, New York, NY 10016, USA. NYU Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA. Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aaa0899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580977PMC
March 2015

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

Cancer 2015 Jan 25;121(1):51-9. Epub 2014 Aug 25.

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York; Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28981DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270907PMC
January 2015

Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

J Natl Compr Canc Netw 2014 Dec;12(12):1706-12

From the Interdisciplinary Melanoma Cooperative Group; and Ronald O. Perelman Department of Dermatology, and Departments of Medicine and Surgery, New York University School of Medicine, New York, New York. From the Interdisciplinary Melanoma Cooperative Group; and Ronald O. Perelman Department of Dermatology, and Departments of Medicine and Surgery, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469335PMC
http://dx.doi.org/10.6004/jnccn.2014.0172DOI Listing
December 2014

Reversal of natural killer cell exhaustion by TIM-3 blockade.

Oncoimmunology 2014 Dec 7;3(12):e946365. Epub 2015 Jan 7.

Tisch Cancer Institute and The Icahn School of Medicine at Mt Sinai ; New York, NY USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/21624011.2014.946
Publisher Site
http://dx.doi.org/10.4161/21624011.2014.946365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353130PMC
December 2014

Enhanced immunohistochemical detection of neural infiltration in primary melanoma: is there a clinical value?

Hum Pathol 2014 Aug 18;45(8):1656-63. Epub 2014 Apr 18.

The New York University Interdisciplinary Melanoma Cooperative Group, 10016, New York, NY; Department of Pathology, New York University School of Medicine, 10016, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.04.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691539PMC
August 2014

Epithelial and stromal expression of miRNAs during prostate cancer progression.

Am J Transl Res 2014 18;6(4):329-39. Epub 2014 Jul 18.

Department of Pathology, New York University School of Medicine New York, USA ; Department of NYU Cancer Institute, New York University School of Medicine New York, USA ; Department of Urology, New York University School of Medicine New York, USA ; Department of New York Harbor Healthcare System, New York University School of Medicine New York, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113495PMC
July 2014

FBXW7 mutations in melanoma and a new therapeutic paradigm.

J Natl Cancer Inst 2014 Jun 16;106(6):dju107. Epub 2014 May 16.

Affiliations of authors: Department of Dermatology (ITY, SJA, AD, DB, JTC) and Department of Pathology (ITA, SJA, MC-M, AD, DB, CC-C, JTC), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Biomedical Informatics (RDM, RR) and Department of Systems Biology (RDM, RR), Columbia University Medical Center, New York, NY; Department of Cancer Research, Skin Cancer Center Hornheide, Munster, Germany (GB); Department of Dermatology, New York University, New York, NY (IO).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/106/6/dju107.full.pdf
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju107
Publisher Site
http://dx.doi.org/10.1093/jnci/dju107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081626PMC
June 2014

Impact of age on the management of primary melanoma patients.

Oncology 2013 30;85(3):173-81. Epub 2013 Aug 30.

Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000351499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842185PMC
April 2014

MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.

Pigment Cell Melanoma Res 2014 Mar 6;27(2):287-96. Epub 2014 Jan 6.

Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12201DOI Listing
March 2014

Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis.

Melanoma Res 2013 Dec;23(6):461-7

aDepartments of Population Health and Environmental Medicine bRonald O. Perelman Department of Dermatology cInterdisciplinary Melanoma Cooperative Group dDepartment of Pathology, New York University School of Medicine eNew York University Cancer Institute, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419696PMC
December 2013

Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo.

Pharmaceuticals (Basel) 2013 Nov 11;6(11):1429-50. Epub 2013 Nov 11.

Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ph6111429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854019PMC
November 2013

Skin disease in individuals with liver and kidney transplants: influence of skin phototype and transplanted organ.

Dermatol Surg 2013 Oct 29;39(10):1539-43. Epub 2013 Jul 29.

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dsu.12277DOI Listing
October 2013

BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.

Cancer Res 2013 Oct 15;73(20):6264-76. Epub 2013 Aug 15.

Authors' Affiliations: Departments of Pathology and Dermatology, New York University School of Medicine; Interdisciplinary Melanoma Cooperative Group, New York University Cancer Institute, New York University Langone Medical Center; Departments of Structural and Chemical Biology and Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Instituto de Salud Carlos III, Majadahonda, Madrid; and Laboratory of Translational Research in Childhood Cancer, Vall d'Hebrón Institut de Recerca (VHIR), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0122-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254777PMC
October 2013

Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.

Am J Surg Pathol 2013 Jun;37(6):882-9

Department of Pathology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31827e50faDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654084PMC
June 2013

In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis.

Front Oncol 2013 31;3:127. Epub 2013 May 31.

Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, NYU Langone Medical Center , New York, NY , USA ; Department of Pathology, NYU School of Medicine , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668495PMC
June 2013

MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.

Carcinogenesis 2012 Oct 12;33(10):1823-32. Epub 2012 Jun 12.

Department of Pathology, NYU Langone Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/carcin/article-lookup/doi/10.1093/c
Publisher Site
http://dx.doi.org/10.1093/carcin/bgs205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529555PMC
October 2012

Single versus multiple primary melanomas: old questions and new answers.

Cancer 2012 Sep 13;118(17):4184-92. Epub 2012 Jan 13.

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27407DOI Listing
September 2012

Histology-specific microRNA alterations in melanoma.

J Invest Dermatol 2012 Jul 3;132(7):1860-8. Epub 2012 May 3.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2011.451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648670PMC
July 2012

Enrollment in clinical trials correlates with improved survival in metastatic melanoma.

Oncology 2011 20;81(5-6):403-9. Epub 2012 Jan 20.

Department of Medicine, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000335000DOI Listing
June 2012

Roles of Polo-like kinase 3 in suppressing tumor angiogenesis.

Exp Hematol Oncol 2012 Apr 18;1(1). Epub 2012 Apr 18.

Department of Environmental Medicine, New York University Langone Medical Center, 57 Old Forge Road, Tuxedo, NY 10987, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2162-3619-1-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506990PMC
April 2012

Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Melanoma Res 2012 Feb;22(1):1-8

Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0b013e32834e6aa0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253944PMC
February 2012

A high proliferative index of recurrent melanoma is associated with worse survival.

Oncology 2011 24;80(3-4):181-7. Epub 2011 Jun 24.

The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000328518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130987PMC
September 2011

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.

Cancer 2011 Apr 8;117(8):1711-20. Epub 2010 Nov 8.

The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine and New York University Cancer Institute, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117025PMC
April 2011

Metastatic balloon cell malignant melanoma: a case report and literature review.

Int J Clin Exp Pathol 2011 Mar 22;4(3):315-21. Epub 2011 Mar 22.

Department of Pathology, New York University School of Medicine, New York, NY 10010, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071665PMC
March 2011

Clinical relevance of SKP2 alterations in metastatic melanoma.

Pigment Cell Melanoma Res 2011 Feb 21;24(1):197-206. Epub 2010 Oct 21.

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2010.00784.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341662PMC
February 2011

Novel PRKAR1A gene mutations in Carney Complex.

Int J Clin Exp Pathol 2010 May 10;3(5):545-8. Epub 2010 May 10.

Department of Pathology, New York University School of Medicine, NY, New York 10010, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897110PMC
May 2010